VICENTE
ALBEROLA CANDEL
EMÉRITO/A UNIVERSIDAD
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (5)
2012
-
Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum
Lung Cancer, Vol. 76, Núm. 3, pp. 354-361
2010
-
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients
Lung Cancer, Vol. 68, Núm. 3, pp. 491-497
2009
-
Lung cancer and treatment in elderly patients: The Achilles Study
Lung Cancer, Vol. 66, Núm. 1, pp. 103-106
-
Predictors of long-term survival in patients with lung cancer included in the Randomized Spanish Lung Cancer Group 0008 Phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapy
Clinical Lung Cancer, Vol. 10, Núm. 3, pp. 180-186
2002
-
Low ERRC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer
Clinical Cancer Research, Vol. 8, Núm. 7, pp. 2286-2291